Best Practice & Research Clinical Rheumatology
Volume 20, Issue 6 , Pages 1029-1044 , December 2006

Infectious arthritis

  • Andrej Tarkowski (Professor of Rheumatology)

      Affiliations

    • Corresponding Author InformationTel.: +46 31 3424712; Fax: +46 31 826791.

References 

  1. Nade S. Septic arthritis. Best Practice & Research Clinical Rheumatology. 2003;17:183–200
  2. Kaandorp CJ, van Schaardenburg D, Krijnen JD, et al. Risk factors for septic arthritis in patients with joint disease. A prospective study. Arthritis and Rheumatism. 1995;38:1819–1825
  3. Dubost JJ, Fis I, Soubrier M, et al. Septic arthritis in rheumatoid polyarthritis. 24 cases and review of the literature. Revue du Rhumatisme (Ed. Française). 1994;61:153–165
  4. Bremell T, Lange S, Svensson L, et al. Outbreak of spontaneous staphylococcal arthritis and osteitis in mouse colony. Arthritis and Rheumatism. 1990;33:1739–1744
  5. Gotschlich EC. Immunity to extracellular bacteria. In:  Paul WE editors. Fundamental immunology. 3rd edn.. New York: Raven Press; 1993;p. 1287–1308
  6. Sheagren JN. Inflammation induced by Staphylococcus aureus. In:  Gallin JI,  Goldstein IM,  Snyderman R editor. Inflammation: Basic principles and clinical correlates. New York: Raven Press; 1998;p. 829–840
  7. Nilsson I-M, Lee JC, Bremell T, et al. The role of polysaccharide microcapsule expression in septicemia and septic arthritis. Infection and Immunity. 1997;65:4216–4221
  8. Höök M, Mc Gavin MJ, Switalski LM, et al. Interaction of bacteria with extracellular matrix proteins. Cell Differentiation and Development. 1990;32:433–438
  9. Ryden C, Maxe I, Ljungh Å, et al. Selective binding of bone sialoprotein to Staphylococcus aureus isolated from patients with osteomyelitis. Lancet. 1987;II:515
  10. Switalski LM, Patti JM, Butcher W, et al. A collagen receptor on Staphylococcus aureus strains isolated from patients with septic arthritis mediates adhesion to cartilage. Molecular Microbiology. 1993;7:99–107
  11. Patti JM, Bremell T, Krajewska-Pietrasik D, et al. The Staphylococcus aureus collagen adhesin is a virulence determinant in experimental septic arthritis. Infection and Immunity. 1994;62:152–161
  12. Josefsson E, Hartford O, O'Brien L, et al. Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant. The Journal of Infectious Diseases. 2001;184:1572–1580
  13. Nilsson I-M, Hartford O, Foster T, Tarkowski A. Alpha and gamma toxins jointly promote S. aureus virulence in septic arthritis. Infection and Immunity. 1999;67:1045–1049
  14. Schlievert PM. Role of superantigens in human disease. The Journal of Infectious Diseases. 1993;167:997–1002
  15. Bremell T, Tarkowski A. Preferential induction of septic arthritis and mortality by superantigen-producing staphylococci. Infection and Immunity. 1995;63:4185–4187
  16. Abdelnour A, Bremell T, Tarkowski A. Toxic shock syndrome toxin-1 contributes to the arthritogenicity of Staphylococcus aureus. The Journal of Infectious Diseases. 1994;170:84–89
  17. Abdelnour A, Bremell T, Holmdahl R, Tarkowski A. Clonal expansion of T lymphocytes causes arthritis and mortality in mice infected with toxic shock syndrome toxin-1 producing staphylococci. European Journal of Immunology. 1994;24:1161–1166
  18. Abdelnour A, Arvidsson S, Bremell T, et al. The accessory gene regulator (agr) controls Staphylococcus aureus virulence in a murine arthritis model. Infection and Immunity. 1993;61:3879–3885
  19. Nilsson IM, Bremell T, Ryden C, et al. Role of staphylococcal accessory gene regulator (sar) in septic arthritis. Infection and Immunity. 1996;64:4438–4443
  20. Jonsson IM, Arvidsson S, Foster SJ, Tarkowski A. Sigma factor B and RsbU are required for virulence in Staphylococcus aureus-induced arthritis and sepsis. Infection and Immunity. 2004;72:6106–6111
  21. Deng G-M, Nilsson IM, Verdrengh M, et al. Intra-articularly localized bacterial DNA containing CpG motifs induces arthritis. Nature Medicine. 1999;5:702–705
  22. Verdrengh M, Tarkowski A. Role of neutrophils in experimental septicemia and septic arthritis induced by Staphylococcus aureus. Infection and Immunity. 1997;65:2517–2521
  23. Sakiniene E, Bremell T, Tarkowski A. Inhibition of nitric oxide synthase (NOS) aggravates Staphylococcus aureus septicaemia and septic arthritis. Clinical and Experimental Immunology. 1997;110:370–377
  24. Sakiniene E, Bremell T, Tarkowski A. Complement depletion aggravates Staphylococcus aureus septicemia and septic arthritis. Clinical and Experimental Immunology. 1999;115:95–102
  25. Jin T, Bokarewa M, Tarkowski A. Urokinase-type plasminogen activator, an endogenous antibiotic. The Journal of Infectious Diseases. 2005;192:429–437
  26. Jin T, Bokarewa M, Tarkowski A. The role of urokinase in innate immunity against Staphylococcus aureus. Microbes & Infection. 2005;7:1170–1175
  27. Gjertsson I, Innocenti M, Matrisian LM, Tarkowski A. Metalloproteinase-7 contributes to joint destruction in Staphylococcus aureus induced arthritis. Microbial Pathogenesis. 2005;38:97–105
  28. Calander AM, Starckx S, Opdenakker G, et al. Matrix metalloproteinase-9 (gelatinase B) deficiency leads to increased severity of Staphylococcus aureus-triggered septic arthritis. Microbes & Infections. 2006;8:1434–1439
  29. Bremell T, Lange S, Holmdahl R, et al. Immunopathological features of rat Staphylococcus aureus arthritis. Infection and Immunity. 1994;62:2334–2344
  30. Gjertsson I, Hörnquist-Hultgren O, Stensson M, et al. Are B lymphocytes of importance in severe Staphylococcus aureus infections?. Infection and Immunity. 2000;68:2431–2434
  31. Abdelnour A, Zhao Y-X, Holmdahl R, Tarkowski A. Major histocompatibility complex class II region confers susceptibility to Staphylococcus aureus arthritis. Scandinavian Journal of Immunology. 1997;45:301–307
  32. Zhao Y-X, Tarkowski A. Impact of interferon-γ receptor deficiency on experimental Staphylococcus aureus septicemia and arthritis. Journal of Immunology. 1995;155:5736–5742
  33. Zhao Y-X, Nilsson I-M, Tarkowski A. The dual role of interferon-γ in experimental Staphylococcus aureus septicemia versus arthritis. Immunology. 1998;93:80–85
  34. Hultgren O, Kopf M, Tarkowski A. Staphylococcus aureus-induced septic arthritis and septic death is decreased in IL-4 deficient mice: role of IL-4 as promotor for bacterial growth. Journal of Immunology. 1998;160:5082–5087
  35. Hultgren O, Eugster HP, Sedgwick JD, et al. TNF/LTα double mutant mice display increased mortality in response to Staphylococcus aureus. Journal of Immunology. 1998;161:5937–5942
  36. Kaandorp CJ, Dinant HJ, van de Laar M, et al. Incidence and sources of native and prosthetic joint infection: a community based prospective survey. Annals of the Rheumatic Diseases. 1997;56:470–475
  37. Shirtliff ME, Mader JT. Acute septic arthritis. Clinical Microbiology Reviews. 2002;15:527–544
  38. Blackburn WD, Dunn TL, Alarcon GS. Infection versus disease activity in rheumatoid arthritis: eight years' experience. The Southern Medical Journal. 1986;79:1238–1241
  39. van der Heijden IM, Wilbrink B, Tchetverikov I, et al. Presence of bacterial DNA and bacterial peptidoglycans in joints of patients with rheumatoid arthritis and other arthritides. Arthritis and Rheumatism. 2000;43:593–598
  40. Nikkari S, Puolakkainen M, Yli-Kerttula U, et al. Ligase chain reaction in detection of chlamydia DNA in synovial fluid cells. The British Journal of Rheumatology. 1977;36:763–765
  41. Mazmanian SK, Liu G, Ton-That H, Schneewind O. Staphylococcus aureus sortase, an enzyme that anchors surface proteins to the cell wall. Science. 1999;285:760–763
  42. Jonsson IM, Mazmanian SK, Schneewind O, et al. On the role of Staphylococcus aureus sortase and sortase-catalyzed surface proteins anchoring in murine septic arthritis. The Journal of Infectious Diseases. 2002;185:1417–1424
  43. Sakiniene E, Bremell T, Tarkowski A. Corticosteroids ameliorate the course of experimental, superantigen-triggered Staphylococcus aureus arthritis. Arthritis and Rheumatism. 1996;39:1596–1605
  44. Verba V, Sakiniene E, Tarkowski A. Beneficial effects of glucocorticosteroids on the course of the hematogenously acquired Staphylococcus aureus nephritis. Scandinavian Journal of Immunology. 1997;45:282–286
  45. Odio CM, Ramirez T, Pharmd GA, et al. Double blind, randomized, placebo-controlled study of dexamethasone therapy for hematogenous septic arthritis in children. The Pediatric Infectious Disease Journal. 2003;22:883–888
  46. Biyani A, Sharma JC. Continuous suction and intermittent irrigation for septic coxitis. Acta orthopaedica Scandinavica. 1988;59:664–666
  47. Verdrengh M, Tarkowski A. Inhibition of septic arthritis by local administration of taurine chloramine, a product of activated neutrophils. Journal of Rheumatology. 2005;32:1513–1517
  48. Jin T, Bokarewa M, Foster T, et al. Staphylococcus aureus resists human defensins by production of staphylokinase, a novel bacterial evasion mechanism. Journal of Immunology. 2004;172:1169–1176
  49. Lee JC. The prospects for developing a vaccine against Staphylococcus aureus. Trends in Microbiology. 1996;4:162–166
  50. McKenney D, Pouliot KL, Wang Y, et al. Broadly protective vaccine for Staphylococcus aureus based on an in vivo-expressed antigen. Science. 1999;284:1523–1527
  51. Nilsson IM, Verdrengh M, Ulrich R, et al. Vaccination with recombinant staphylococcal enterotoxin A devoid of superantigenicity protects against Staphylococcus aureus sepsis. The Journal of Infectious Diseases. 1999;180:1370–1373
  52. Collins LV, Eriksson K, Ulrich RG, Tarkowski A. Mucosal tolerance to a bacterial superantigen indicates a novel pathway to prevent toxic shock. Infection and Immunity. 2002;70:2282–2287
  53. Schennings T, Heimdahl A, Coster K, Flock JI. Immunization with fibronectin binding protein from Staphylococcus aureus protects against experimental endocarditis in rats. Microbial Pathogenesis. 1993;15:227–236
  54. Nilsson I-M, Patti JM, Bremell T, et al. Vaccination with a recombinant fragment of collagen adhesin provides protection against Staphylococcus aureus-mediated septic death. The Journal of Clinical Investigations. 1998;101:2640–2649
  55. Verdrengh M, Carlsten H, Ohlsson C, Tarkowski A. Addition of bisphosphonate to antibiotic and anti-inflammatory treatment reduces bone resorption in experimental Staphylococcus aureus-induced arthritis. Journal of Orthopaedic Research. 2006;[in press]

PII: S1521-6942(06)00105-7

doi: 10.1016/j.berh.2006.08.001

Best Practice & Research Clinical Rheumatology
Volume 20, Issue 6 , Pages 1029-1044 , December 2006

Article Tools